BC Extra | Jan 14, 2020
Company News

Adaptimmune continues upward trajectory with Astellas allogeneic cell therapy deal

Adaptimmune continued its run of J.P. Morgan news Tuesday, announcing a discovery partnership with Japanese pharma Astellas to develop allogeneic T cell therapies for cancer. The announcement follows a 200% gain for Adaptimmune Therapeutics plc...
Items per page:
1 - 1 of 1